Department of Molecular Neurology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Schwabachanlage 6, 91054, Erlangen, Germany.
Fraunhofer Institute for Integrated Circuits IIS, Erlangen, Germany.
J Patient Rep Outcomes. 2023 Oct 30;7(1):106. doi: 10.1186/s41687-023-00631-6.
Exercise therapy is considered effective for the treatment of motor impairment in patients with Parkinson's disease (PD). During the COVID-19 pandemic, training sessions were cancelled and the implementation of telerehabilitation concepts became a promising solution. The aim of this controlled interventional feasibility study was to evaluate the long-term acceptance and to explore initial effectiveness of a digital, home-based, high-frequency exercise program for PD patients. Training effects were assessed using patient-reported outcome measures combined with sensor-based and clinical scores.
16 PD patients (smartphone group, SG) completed a home-based, individualized training program over 6-8 months using a smartphone app, remotely supervised by a therapist, and tailored to the patient's motor impairments and capacity. A control group (CG, n = 16) received medical treatment without participating in digital exercise training. The usability of the app was validated using System Usability Scale (SUS) and User Version of the Mobile Application Rating Scale (uMARS). Outcome measures included among others Unified Parkinson Disease Rating Scale, part III (UPDRS-III), sensor-based gait parameters derived from standardized gait tests, Parkinson's Disease Questionnaire (PDQ-39), and patient-defined motor activities of daily life (M-ADL).
Exercise frequency of 74.5% demonstrated high adherence in this cohort. The application obtained 84% in SUS and more than 3.5/5 points in each subcategory of uMARS, indicating excellent usability. The individually assessed additional benefit showed at least 6 out of 10 points (Mean = 8.2 ± 1.3). From a clinical perspective, patient-defined M-ADL improved for 10 out of 16 patients by 15.5% after the training period. The results of the UPDRS-III remained stable in the SG while worsening in the CG by 3.1 points (24%). The PDQ-39 score worsened over 6-8 months by 83% (SG) and 59% (CG) but the subsection mobility showed a smaller decline in the SG (3%) compared to the CG (77%) without reaching significance level for all outcomes. Sensor-based gait parameters remained constant in both groups.
Long-term training over 6-8 months with the app is considered feasible and acceptable, representing a cost-effective, individualized approach to complement dopaminergic treatment. This study indicates that personalized, digital, high-frequency training leads to benefits in motor sections of ADL and Quality of Life.
运动疗法被认为对治疗帕金森病(PD)患者的运动障碍有效。在 COVID-19 大流行期间,培训课程被取消,远程康复概念的实施成为一种有前途的解决方案。这项对照干预可行性研究的目的是评估一种数字、家庭、高频运动方案对 PD 患者的长期接受程度,并探索其初步效果。使用基于传感器和临床评分的患者报告结果测量来评估训练效果。
16 名 PD 患者(智能手机组,SG)使用智能手机应用程序在家中完成了 6-8 个月的个性化训练计划,该应用程序由治疗师远程监督,并根据患者的运动障碍和能力进行调整。对照组(CG,n=16)接受了药物治疗,而不参与数字运动训练。使用系统可用性量表(SUS)和用户移动应用程序评级量表(uMARS)验证了应用程序的可用性。结果测量包括统一帕金森病评定量表第三部分(UPDRS-III)、从标准化步态测试中得出的基于传感器的步态参数、帕金森病问卷(PDQ-39)以及患者定义的日常生活活动(M-ADL)的运动部分。
该队列的运动频率为 74.5%,表明具有很高的依从性。该应用程序在 SUS 中获得了 84%的分数,在 uMARS 的每个子类别中都获得了超过 3.5/5 分,表明其具有极好的可用性。从临床角度来看,经过训练期后,16 名患者中有 10 名患者的患者定义的 M-ADL 改善了 15.5%。SG 的 UPDRS-III 结果保持稳定,而 CG 的结果恶化了 3.1 分(24%)。PDQ-39 评分在 6-8 个月内恶化了 83%(SG)和 59%(CG),但 SG 的移动部分下降幅度较小(3%),而 CG 的下降幅度较大(77%),但所有结果均未达到显著水平。基于传感器的步态参数在两组中均保持不变。
经过 6-8 个月的应用程序长期训练被认为是可行和可接受的,代表了一种具有成本效益的、个性化的方法,可以补充多巴胺治疗。本研究表明,个性化、数字化、高频训练可改善日常生活活动和生活质量的运动部分。